About The Study: Results of this randomized clinical trial that included 4,100 patients with hypertension showed that a multicomponent intervention delivered on a web-based platform improved blood pressure control rate and lowered blood pressure level more than usual care alone. Such a telemedicine program may provide a new, effective way to treat patients with hypertension in the community and may generate public health benefits across diverse populations.
Authors: Zengwu Wang, M.D., Ph.D., of Peking Union Medical College & Chinese Academy of Medical Sciences in Beijing, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.45439)
